Overcoming the Risk-Treatment Paradox for Non-ST-Segment Elevation Acute Coronary Syndromes

J Am Coll Cardiol. 2019 Sep 17;74(11):1462-1464. doi: 10.1016/j.jacc.2019.07.031.

Authors

Matthew T Roe¹, Guillaume Marquis-Gravel²

Affiliations

¹ Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina. Electronic address: matthew.roe@duke.edu.
² Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.

PMID: 31514948
DOI: 10.1016/j.jacc.2019.07.031

No abstract available

Keywords: acute coronary syndrome; coronary revascularization; country; mortality; region; risk.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Acute Coronary Syndrome*
Heart Rate
Humans
Myocardial Infarction*
Patient Discharge